Stockwatch: Taking The Temperature In San Francisco
This article was originally published in Scrip
The run-up to registration for last week's annual JP Morgan Healthcare conference was distinctly lackluster. At that point, the tough start of the year in life sciences could still have been rescued from depressed broad stock markets by a wave of pre-conference announcements of acquisitions at big premiums, and a bolus of positive earnings pre-announcements.
Register for our free email digests: